198 related articles for article (PubMed ID: 4055162)
1. Pharmacokinetics of norfloxacin in chronic renal failure.
Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
[TBL] [Abstract][Full Text] [Related]
2. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
3. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
Wu MJ; Ing TS; Soung LS; Daugirdas JT; Hano JE; Gandhi VC
Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
[TBL] [Abstract][Full Text] [Related]
4. Doses of antibiotic in patients with renal insufficiency.
Ohkawa M; Kuroda K
Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
[TBL] [Abstract][Full Text] [Related]
5. The kinetics of aminosidine in renal patients with different degrees of renal failure.
Novarini A; Montanari A; Bruschi G; Rossi E; Borghetti A; Migone L
Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346
[TBL] [Abstract][Full Text] [Related]
6. Butofilolol pharmacokinetics in chronic renal insufficiency.
Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
Kowalsky SF; Echols RM; Parker MA
Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ofloxacin in severe chronic renal failure.
Bandai H; Tsubakihara Y; Yamato E; Yokoyama K; Okada N; Nakanishi I; Iida N
Clin Ther; 1989; 11(2):210-8. PubMed ID: 2736567
[TBL] [Abstract][Full Text] [Related]
10. Serum levels and half-life of sotalol in chronic renal failure.
Sundquist HK; Anttila M; Forsström J; Kasanen A
Ann Clin Res; 1975 Dec; 7(6):442-6. PubMed ID: 1211858
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of teicoplanin in burn patients.
Potel G; Moutet J; Bernareggi A; Le Normand Y; Meigner M; Baron D
Scand J Infect Dis Suppl; 1990; 72():29-34. PubMed ID: 2151064
[TBL] [Abstract][Full Text] [Related]
12. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of anakinra in subjects with different levels of renal function.
Yang BB; Baughman S; Sullivan JT
Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cicletanine in patients with impaired renal function.
Jungers P
Drugs Exp Clin Res; 1988; 14(2-3):189-94. PubMed ID: 3416723
[TBL] [Abstract][Full Text] [Related]
15. A study of practolol elimination in all grades of chronic renal failure.
Kaye CM; Kumana CR; Franklin DA; Baker LR
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin disposition in children with chronic renal failure.
Berry PL; Kearns GL; Brown RD; Ritschel WA; Thompson GA; McEnery PT
Pediatr Pharmacol (New York); 1982; 2(4):257-73. PubMed ID: 6927126
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
19. Alprazolam kinetics in patients with renal insufficiency.
Ochs HR; Greenblatt DJ; Labedzki L; Smith RB
J Clin Psychopharmacol; 1986 Oct; 6(5):292-4. PubMed ID: 3771810
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
